BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 277230)

  • 1. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
    Rockwell S
    Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
    Shibamoto Y; Ono K; Takahashi M; Kano E; Hori H; Shibata T; Inayama S; Abe M
    Jpn J Cancer Res; 1986 Oct; 77(10):1027-33. PubMed ID: 3096918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
    Gomer CJ; Johnson RJ; Hetzel FW; Lawrence G
    Br J Cancer Suppl; 1978 Jun; 3():228-31. PubMed ID: 277234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.
    Brown JM; Yu NY; Cory MJ; Bicknell RB; Taylor DL
    Br J Cancer Suppl; 1978 Jun; 3():206-11. PubMed ID: 277229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
    Rockwell S; Irvin CG; Nierenburg M
    Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK; Hurst S; Begg AC; Brown JM
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic and radiosensitizing effect of the 2-nitroimidazole misonidazole (Ro-07-0582) on murine CFU in vivo.
    Pettersen EO
    Br J Cancer Suppl; 1978 Jun; 3():107-10. PubMed ID: 277208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors.
    Rockwell S; Schulz RJ
    Radiat Res; 1984 Dec; 100(3):527-35. PubMed ID: 6505142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 2-amino-5-nitrothiazole as a hypoxic cell radiosensitizer.
    Rockwell S; Mroczkowski Z; Rupp WD
    Radiat Res; 1982 Jun; 90(3):575-85. PubMed ID: 7045963
    [No Abstract]   [Full Text] [Related]  

  • 13. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM; Chin J; Marchow L; Paciga J
    Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
    Twentyman PR
    Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
    Rockwell S; Kelley M
    Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.
    Sutherland R; Macfarlane W
    Br J Cancer Suppl; 1978 Jun; 3():168-72. PubMed ID: 277220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizers: rationale and potential.
    Brown JM
    Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.